Pfizer's experimental weight loss pill, danuglipron, has joined the list of obesity drugs that have been scrapped due to adverse side effects. This development...

Pfizer's experimental weight loss pill, danuglipron, has joined the list of obesity drugs that have been scrapped due to adverse side effects. This development highlights the ongoing challenges in creating effective and safe weight loss treatments. Key Takeaways: Pfizer's twice-daily weight loss pill, danuglipron, has been discontinued. The decision follows adverse side effects observed in a midstage clinical trial. Pfizer had previously scrapped another once-daily pill in June due to elevated liver enzymes. The difficulty in developing safe and effective obesity treatments is evident, despite recent successful drugs like Wegovy, Ozempic, and Mounjaro. An estimated 40% of U.S. adults are obese, making effective treatments highly sought after. Past obesity drugs have been scrapped due to unintended...

NASA's Curiosity Rover has marked a significant milestone by reaching 4,000 Martian days, or sols, on the Red Planet. Since its touchdown in Gale Crater on August 5, 2012, the rover has been a workhorse of science and exploration on Mars. Enduring Explorer Curiosity has been on Mars for 4,000 sols. The rover recently drilled its 39th sample for analysis. It is exploring Mount Sharp to study Mars' past habitability. Scientific Pursuits The rover's mission to determine if Mars ever had the conditions to support microbial life continues as it ascends Mount Sharp. This journey through the Martian geological record is revealing how the planet's climate has changed. The latest sample from a site named "Sequoia" may shed...